<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-129275</identifier>
<setSpec>0212-6567</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">An analysis of the diabetic population in a Spanish rural are: morbidity profile, use of resources, complications and metabolic control</dc:title>
<dc:description xml:lang="en">Objective: To describe the characteristics of a diabetic population, morbidity profile, resource consumption, complications and degree of metabolic control. Design: Cross-sectional study during 2010.Location: Four Health Areas (91.301 people) where the integrated management organization Serveis de Salut integrated Baix Empordà completely provide healthcare assistance. Participants: 4.985 diabetic individuals, identified through clinical codes using the ICD-9-MC classification and the 3M? Clinical Risk Groups software. Main measurements: Morbidity profile, related complications and degree of metabolic control were obtained for the target diabetic population. We analyzed the consumption of healthcare resources, pharmaceutical and blood glucose reagent strips. All measurements obtained at individual level. Results: 99.3% of the diabetic population were attended at least once at a primary care center (14.9% of visits). 39.5% of primary care visits and less than 10% of the other scanned resources were related to the management of diabetes. The pharmaceutical expenditure was 25.4% of the population consumption (average cost ? 1.014,57). 36.5% of diabetics consumed reagents strips (average cost ?120,65). The more frequent CRG are 5424-Diabetes (27%); 6144-Diabetesand Hypertension (25,5%) and 6143-Diabetes and Other Moderate Chronic Disease (17,2%). The degree of disease control is better in patients not consumers of antidiabetic drugs or treated with oral antidiabetic agents not secretagogues. Conclusions: Comorbidity is decisive in the consumption of resources. Just a few part of this consumption is specifically related to the management of diabetes. Results obtained provide a whole population approach to the main existing studies in our national and regional context (AU)</dc:description>
<dc:creator>Cols, Montse</dc:creator>
<dc:creator>Coderch, Jordi</dc:creator>
<dc:creator>Pérez, Marc</dc:creator>
<dc:creator>Carreras, Marc</dc:creator>
<dc:creator>Sánchez, Inma</dc:creator>
<dc:creator>Inoriza, José M</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">Objetivo: Describir las características de una población diabética, perfil de morbilidad, consumo de recursos, complicaciones y grado de control. Diseño: Estudio transversal durante 2010.EmplazamientoCuatro Áreas Básicas de Salud (91.301 personas) donde la organización sanitaria integrada Serveis de Salut Integrats Baix Empordà cubre la asistencia. Participantes: Se han identificado 4.985 diabéticos, utilizando la codificación clínica de los contactos mediante CIE-9-MC y Clinical Risk Groups. Mediciones principales: Perfil de morbilidad de los diabéticos, complicaciones y grado de control metabólico. Se analiza el consumo de recursos asistenciales, farmacéutico y de tiras reactivas de glucemia. Todas las mediciones a nivel individual. Resultados: El 99,3% de los diabéticos acudió al menos una vez al centro de salud (14,9% del total de visitas). El 39,5% de las visitas de atención primaria y menos del 10% del resto de recursos analizados se dedicaron a la gestión de la diabetes. El coste de farmacia representa el 25,4% del consumo total de la población (coste medio 1.014,57?). El 36,5% de los diabéticos consumió tiras reactivas (coste medio 120,65?). Los CRG base más comunes son 5424-Diabetes (27%); 6144-Diabetes and Hypertension (25,5%) y 6143-Diabetes and Other Moderate Chronic Disease (17,2%). El grado de control de la enfermedad es mejor en pacientes que no toman fármacos o toman antidiabéticos orales no secretagogos. Conclusiones: La comorbilidad es determinante en el consumo de recursos. Solo una parte de este consumo está dedicado al manejo de la diabetes. Los resultados obtenidos son consistentes y complementan desde un punto de vista poblacional los estudios existentes de ámbito estatal y autonómico (AU)</dc:description>
<dc:source>Aten Primaria;45(9): 461-475, nov. 2013. tab, graf</dc:source>
<dc:identifier>ibc-129275</dc:identifier>
<dc:title xml:lang="es">Análisis de la población diabética de una comarca: perfil de morbilidad, utilización de recursos, complicaciones y control metabólico</dc:title>
<dc:subject>^d29611</dc:subject>
<dc:subject>^d3942^s22080</dc:subject>
<dc:subject>^d38644^s22080</dc:subject>
<dc:subject>^d^s22083</dc:subject>
<dc:subject>^d22190^s22002</dc:subject>
<dc:subject>^d12368</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d53262^s22083</dc:subject>
<dc:subject>^d24572</dc:subject>
<dc:type>article</dc:type>
<dc:date>201311</dc:date>
</metadata>
</record>
</ibecs-document>
